product-certification
C4134-0000-002 - Drug Test Kit, 01-102-2023, 6 Drug iCup® A.D.

C4134-0000-002 - Drug Test Kit, 01-102-2023, 6 Drug iCup® A.D.

C4135-0000-008 - Drug Test Kit, 01-102-0004, 1 Panel-Dip Card

C4135-0000-008 - Drug Test Kit, 01-102-0004, 1 Panel-Dip Card

C4135-0000-007 - Drug Test Kit, 01-102-0036, 1 Panel-Dip Card

$9.62
SKU
C4135-0000-007

Reditest® Panel-Dip Card, 1 drug; Redwood #01-102-0036. Testing for MDMA*.

Reditest® Panel-Dip, available in single and multi-drug urine test configurations: AMP, BAR, BUP, BZO, COC, EDDP, M-AMP, MDMA, MTD, OPI, OXY, PCP, PPX, TCA and THC*.
FDA 510(k) Cleared. Simple procedure: collect, dip and read results at 5 minutes.

Ordering Information:
Priced per case of 25 cards.

INTENDED USE STATEMENTS

  1. FOR PROFESSIONAL INVITRO DIAGNOSTIC USE ONLY.

DRUG LEGEND*
DRUG SCREENS: Amphetamine (AMP1000 or AMP300), Barbiturates (BAR), Benzodiazepines (BZO), Buprenorphine (BUP), Cocaine Metabolites (COC150 or COC300), Marijuana (THC), MDMA (Ecstasy), Methadone (MTD), Methamphetamine (M-AMP), Opiates (OPI300 or OPI2000), Oxycodone (OXY), Phencyclidine (PCP), Propoxyphene (PPX) and Tricyclic Antidepressants (TCA).

SPECIMEN VALIDITY TESTS: Creatinine (CR), Glutaraldehyde (GL), Nitrate (NI), Oxidants (OX), ph (PH), Specific Gravity (SG).

PRODUCT PROCEDURE NOTE:
Refer to product insert for complete instructions, limitations, and warnings.

This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) or liquid chromatography/tandem mass spectrometry (LC/MS/MS) are the preferred confirmatory methods. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.

Write Your Own Review
You're reviewing:C4135-0000-007 - Drug Test Kit, 01-102-0036, 1 Panel-Dip Card

Product Attachments